← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #199 OF 1,000 MOST-CITED

Label to bear a unique device identifier

FDA cited this observation 116 times across 115 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Devices116
BY FISCAL YEAR
FY202627
FY202550
FY202436
FY20233

How FDA worded it — real examples

The labels of the medical device(s) do not bear a unique device identifier (UDI) that meet the requirements of 801 Subpart B and 21 CFR 830.

Comfortland Medical, Inc. · Mebane, North Carolina · Devices · 2026-06-12

The labels of the medical device(s) do not bear a unique device identifier (UDI) that meet the requirements of 801 Subpart B and 21 CFR 830.

Bluewave Technologies Inc · Orange City, Florida · Devices · 2026-05-22

The labels of the medical device(s) do not bear a unique device identifier (UDI) that meet the requirements of 801 Subpart B and 21 CFR 830.

MDI East Inc., DBA Aptyx · South Glens Falls, New York · Devices · 2026-05-21

The labels of the medical device(s) do not bear a unique device identifier (UDI) that meet the requirements of 801 Subpart B and 21 CFR 830.

Perry Dynamics Inc · Decatur, Illinois · Devices · 2026-05-20

The labels of the medical device(s) do not bear a unique device identifier (UDI) that meet the requirements of 801 Subpart B and 21 CFR 830.

Michael Todd Beauty LP · Port St Lucie, Florida · Devices · 2026-05-20

The labels of the medical device(s) do not bear a unique device identifier (UDI) that meet the requirements of 801 Subpart B and 21 CFR 830.

PureWave Life LLC · Boynton Beach, Florida · Devices · 2026-04-29

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Medical device qualityMedical devices

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →